Longitudinal monitoring of pediatric cystic fibrosis lung disease using nitrite in exhaled breath condensate

Cystic fibrosis (CF) lung disease is characterized by airway inflammation and airway infection. Nitrites in exhaled breath condensate (EBC‐NO  2− ) have been shown to be increased in children and adults with CF compared to healthy controls suggesting its use as a measure of airway inflammation. This longitudinal study aimed to evaluate if repeated measurements of EBC‐NO  2− are helpful in monitoring CF lung disease activity in children. Thirty‐two children with mild CF lung disease (age 10.6 ± 3.3 years) were recruited in two study centers. Follow‐up visits occurred every 3 months over a period of 1 year with a total of five visits. Each visit included a clinical assessment incorporating a modified Shwachman–Kulczycki (SK) score, spirometry, an oropharyngeal swab, or sputum sample for bacterial analysis and an EBC sample analyzed for NO  2− using a spectrophotometric assay. Furthermore at the first and the last visit a chest radiograph was done and scored (Chrispin–Norman (CN) score). There was no correlation of EBC‐NO  2− and parameters of spirometry, SK‐score, or CN‐score. Furthermore, increased EBC‐NO  2− levels did not predict subsequent pulmonary exacerbations. We conclude that repeated measurements of EBC‐NO  2− are not helpful in the longitudinal monitoring of mild CF lung disease in children. Pediatr Pulmonol. 2007; 42:1198–1206. © 2007 Wiley‐Liss, Inc.

[1]  I. Horváth,et al.  ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. , 2006, Proceedings of the American Thoracic Society.

[2]  D. Knight,et al.  Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis , 2006, Thorax.

[3]  S. Stick,et al.  Variability of nitric oxide metabolites in exhaled breath condensate. , 2006, Respiratory medicine.

[4]  N. Wilson,et al.  Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. , 2005, American journal of respiratory and critical care medicine.

[5]  G L Hall,et al.  Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation , 2005, Thorax.

[6]  J. Hamacher,et al.  The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. , 2005, Chest.

[7]  A. Morice,et al.  Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis , 2004, Thorax.

[8]  A. Chrispin,et al.  The systematic evaluation of the chest radiograph in cystic fibrosis , 2005, Pediatric Radiology.

[9]  N. Kiper,et al.  BALF Nitrite as an Indicator of Inflammation in Children with Cystic Fibrosis , 2004, Respiration.

[10]  Q. Jöbsis,et al.  Exhaled breath condensate in children: Pearls and pitfalls , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[11]  R. Shaker,et al.  A simple method for estimating respiratory solute dilution in exhaled breath condensates. , 2003, American journal of respiratory and critical care medicine.

[12]  V. Gulmans,et al.  Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters , 2003, Pediatric pulmonology.

[13]  Giovanna E Carpagnano,et al.  Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[14]  J. Innes,et al.  Airways in cystic fibrosis are acidified: detection by exhaled breath condensate , 2002, Thorax.

[15]  J. Weil,et al.  Nitric oxide and protein nitration in the cystic fibrosis airway. , 2002, Archives of biochemistry and biophysics.

[16]  George M. Hilliard,et al.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. , 2002, Developmental cell.

[17]  J. Hunt,et al.  Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. , 2002, The Journal of allergy and clinical immunology.

[18]  N. Wilson,et al.  Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance , 2002, Thorax.

[19]  B. Gaston,et al.  How acidopneic is my patient? A new question in the pulmonary laboratory. , 2002, American journal of respiratory and critical care medicine.

[20]  R. Henry,et al.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[21]  U. Frey,et al.  Elevated nitrite in breath condensates of children with respiratory disease , 2002, European Respiratory Journal.

[22]  M. Gare,et al.  Dilution of respiratory solutes in exhaled condensates. , 2002, American journal of respiratory and critical care medicine.

[23]  J. Goldberg,et al.  Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. , 2002, American journal of respiratory and critical care medicine.

[24]  J. Rosenecker,et al.  Diabetes mellitus and cystic fibrosis: Comparison of clinical parameters in patients treated with insulin versus oral glucose‐lowering agents , 2001, Pediatric pulmonology.

[25]  D. Koller,et al.  The relationship of eosinophil granule proteins to ions in the sputum of patients with cystic fibrosis , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  M. Grisham,et al.  Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum , 2000, Pediatric pulmonology.

[27]  W. Hop,et al.  Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. , 2000, The European respiratory journal.

[28]  S. Cunningham,et al.  Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. , 2000, The European respiratory journal.

[29]  B. Gaston,et al.  Endogenous airway acidification. Implications for asthma pathophysiology. , 2000, American journal of respiratory and critical care medicine.

[30]  J. Polak,et al.  Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells , 2000 .

[31]  L. Ho,et al.  Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. , 1998, The European respiratory journal.

[32]  L. Ho,et al.  Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide , 1998, Thorax.

[33]  J. Hull,et al.  Elemental content of airway surface liquid from infants with cystic fibrosis. , 1998, American journal of respiratory and critical care medicine.

[34]  J. Carlin,et al.  Lower airway inflammation in infants and young children with cystic fibrosis. , 1997, American journal of respiratory and critical care medicine.

[35]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[36]  M. Weinberger,et al.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis , 1995, Pediatric pulmonology.

[37]  J. Stamler,et al.  The biology of nitrogen oxides in the airways. , 1994, American journal of respiratory and critical care medicine.

[38]  A. Gessner,et al.  Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. , 1990, Journal of medical microbiology.

[39]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[40]  H. Shwachman,et al.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. , 1958, A.M.A. journal of diseases of children.